A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2840

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study ; volume:20 ; number:1 ; day:2 ; month:2 ; year:2021 ; pages:1-13 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (2.2.2021), 1-13, 12.2021

Creator: Hiruma, Shigenori
Shigiyama, Fumika
Hisatake, Shinji
Mizumura, Sunao
Shiraga, Nobuyuki
Hori, Masaaki
Ikeda, Takanori
Hirose, Takahisa
Kumashiro, Naoki

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12933-021-01228-3

URN: urn:nbn:de:101:1-2021032620080051477194

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hiruma, Shigenori
Shigiyama, Fumika
Hisatake, Shinji
Mizumura, Sunao
Shiraga, Nobuyuki
Hori, Masaaki
Ikeda, Takanori
Hirose, Takahisa
Kumashiro, Naoki
SpringerLink (Online service)

Other Objects (12)

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Aufsatzsammlung

Cardiac CT

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Aufsatzsammlung

Cardiac CT

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Aufsatzsammlung

Cardiac CT

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Cardiac CT

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Cardiac CT

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study

Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR

Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Predicting cardiac arrest after neonatal cardiac surgery

Traumatic cardiac arrest – a nationwide Danish study

Cardiac CT

Related objects

Reset password